Biotech Investors & VC Firms in United States
1619 firms in this list, with a median first check of $500K. 402 of them lead rounds. Generated from verified public data and updated continuously.
Dynamk Capital
New YorkSeed–Series B
4 people
Inning One Ventures
New York
3 people
Bija Ventures
AspenPre-Seed–Series A
2 people
MB Venture Partners
MemphisPre-Seed–Growth
2 people
NPU Ventures
BerkeleyPre-Seed–Seed
2 people
Sustainable Conversion Ventures
Sun LakesSeries B–Late Stage
2 people
Blue Ledge Capital
New YorkSeed–Series A
1 person
Crede CapitalGroup
Los Angeles$5M – $50M
ROC Venture Group
NaplesSeed–Series A
Tamil Ventures
San FranciscoPre-Seed–Series A$100K – $250K
Good Ventures
Seed
2 people
BioRock Ventures
San FranciscoSeed–Series A
1 person
Global Health Investment Fund
New York
1 person
Asclepius Life Sciences Fund, LP
New YorkSeed–Series B
3 people
M31 Capital
New York City
3 people
Rhythm Venture Capital
New YorkSeed–Series A
3 people
Fulcrum Financial Partners
Raleigh-DurhamPre-Seed–Seed
2 people
SRI Ventures
Menlo ParkPre-Seed–Seed
2 people
Walder Ventures
ChicagoSeed
2 people
Curative Ventures
Dallas
1 person
Paragon Biosciences LLC
ChicagoSeed–Series A
1 person
View Ventures
DallasSeed–Series A
1 person
De Novo Ventures
Boston
6 people
Trans-it Capital
Palo AltoSeed
1 person
Related lists
Investors & VC Firms in North America (13326)Investors & VC Firms in United States (12318)Investors & VC Firms in Europe (6083)AI & Machine Learning Investors & VC Firms (5352)Investors & VC Firms in Global (5318)Fintech Investors & VC Firms (5140)Healthtech Investors & VC Firms (4657)SaaS Investors & VC Firms (4528)Enterprise Software Investors & VC Firms (4424)Crypto & Web3 Investors & VC Firms (4140)
Data sourced from public filings and firms' own websites — see our methodology.



























